Stay updated on Propranolol and Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Propranolol and Pembrolizumab in Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows revision v3.5.4, indicating a maintenance/update to the page. There are no changes to the trial details or content evident in this revision.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3, reflecting a site/software release rather than a change to the underlying clinical trial information.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded revision: v3.5.2 and removed revision: v3.5.0.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.5.0 is now active, replacing v3.4.3.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check105 days agoChange DetectedRevision: v3.4.2 was added. The government funding lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

Stay in the know with updates to Propranolol and Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.